Background and Purpose: Recent literature has suggested that higher volumes of practice areassociated with better survival outcomes for head and neck cancer (HNC) patients. However,these studies are limited by looking at the volume of practice on a cancer centre level (i.e. notprovider level), and include jurisdictions without central coordination and specialized HNCtumor group support. The objective of this thesis was to evaluate the effect of treatment centre onthe overall survival (OS) and cancer-specific survival (CSS) of HNC patients in BritishColumbia in a provincially coordinated program.Methods: The BC Cancer Registry (BCCR), a population-based provincial database, was used toidentify all patients in BC diagnosed for the first time with a primary non-thyroid HNC andtreated with radiotherapy between 2006 and 2011. Patients were categorized as residing in large,small and rural local health authorities (LHAs) using BC Stats and BC Ministry of Healthinformation. Physician case frequency was defined as low (0-14 cases per year), medium (15-29cases per year) and high (>30 cases per year). There was no effect on OS or head and neck CSSwhen physician case frequency was treated as a continuous variable.Results: 2,330 HNC patients were included in the study. On multivariable analysis, aftercontrolling for age, gender, cancer stage, anatomical site, treatment and physician casefrequency, neither head and neck CSS (HNCSS) (HR range=0.86-1.03; p=0.54-0.99) nor OS(HR range=0.91-1.05; p=0.60-0.88) was significantly different by centre. OS was also notsignificantly different for patients treated by physicians with low case frequency (HR=0.96;0.81-1.13; p=0.60) and medium case frequency (HR=1.12; 0.84-1.49; p=0.43) in reference tohigh case frequency. Conclusions: There was no significant difference in survival among BC cancer centres aftercontrolling for differences in rurality, physician case volume and other potential confoundingvariables. This lack of difference may be in large part due to the centrally coordinatedpopulation-run program where radiation oncologists subspecialize, follow provincial guidelines,attend multidisciplinary rounds, have access to radiotherapy quality assurance, and are supportedby a HNC tumor group.
View record